Xenon Pharmaceuticals

XENE

NASDAQHealth Care

Income Statement

Total Revenue$0

Gross Profit$0

Operating Income$-279.3M

EBITDA$-234.61M

EBIT$-238.42M

Pre-tax Income$-385.15M

Net Income$-234.33M

Cash Equivalent$106.49M

Total Debt$9.81M

Book Value$821.11M

Book Value Per Share10.84

Return on Equity (ROE)-31.04%

Return on Assets (ROA)-29.36%

Return on Invested Capital (ROI)-31.04%

Net Profit Margin-1329.48%

Current Ratio17.85

Quick Ratio17.66

Long-Term Debt / Equity0.00